#Singapore #NUS #microneedles #diabetic wounds

Enhancing Wound Healing with Microneedles

Recent advancements in medical technology aim to address chronic issues faced by patients with diabetic wounds, a condition affecting millions globally. Presently, diabetic wounds are notorious for leading to severe complications, including amputations.

In Singapore alone, statistics highlight the alarming reality of approximately four lower limb amputations occurring daily due to diabetic wounds, which often do not heal adequately. This situation necessitates innovative solutions, and researchers from the National University of Singapore (NUS) are leading the charge with groundbreaking microneedle technology that shows promise in accelerating wound healing.

Understanding the Challenge

Diabetic wounds frequently exhibit persistent inflammation and are resistant to conventional treatment methods. A study conducted in Singapore highlighted that the healthcare costs associated with amputations due to non-healing diabetic wounds can exceed S$23,000 per patient, indicating the pressing need for effective treatment options.

To address these challenges, the NUS research team has developed two distinct microneedle technologies that perform dual functions: preserving vital growth factors and removing harmful inflammatory compounds. By tackling these two critical issues, the team aims to improve recovery outcomes for patients.

The Microneedle Technologies

1. Growth Factor Delivery through Sucralfate Microneedles (SUC-MN)

In the first approach, the team has engineered microneedles to deliver a immunomodulatory protein known as interleukin-4 (IL-4) directly to the site of the wound. The idea is to stimulate the natural production of growth factors in diabetic tissues, which are essential for healing but are often degraded by enzymes, slowing down recovery. By using sucralfate in the microneedles to protect growth factors from degradation, this system minimizes the need for frequent high-dose applications.

The results indicate that when compared to standard treatments, the SUC-MN approach significantly enhances wound healing speed—approximately doubling the healing pace. This method not only accelerates recovery but also mitigates potential side effects associated with traditional dressing techniques.

2. Extractive Microneedles (HPMN) for Inflammatory Control

In a pioneering shift, the NUS researchers utilized microneedles for extraction purposes, targeting undesirable inflammatory proteins within the wound site. Finding a coating material that could effectively absorb pro-inflammatory compounds was critical. This led them to the use of heparin-coated porous microneedles (HPMN), a substance known for its ability to bind with inflammatory chemokines.

The HPMN technology demonstrated remarkable efficacy by reducing tissue inflammation by 50% and decreasing wound size by 90% in just two weeks of treatment. These microneedles target the root of inflammation in skin wounds, providing a unique edge over existing treatment methods that only address surface symptoms.

Future Directions and Implications

The successful development of SUC-MN and HPMN represents a significant leap forward in wound care technologies. The researchers at NUS are poised to further investigate these technologies, aspiring to bring them to clinical application. Future studies aim to create microneedles with customizable pore sizes using advanced techniques such as 3D printing and integrate antibacterial properties to combat infections commonly associated with non-healing wounds.

According to Assistant Professor Andy Tay, who led the research team, these innovations not only herald a new era for patients suffering from diabetic wounds but also other skin conditions, including psoriasis and dermatitis. The anticipated impact of these microneedles could transform wound management, providing personalized and effective treatments tailored to individual patient needs.

Conclusion

As the NUS research team progresses towards clinical trials, the hope remains that these microneedles will soon become commonplace in the treatment arsenal for diabetic wounds, alleviating the burden these conditions place on patients worldwide and significantly improving their quality of life.